We found three clinical entities divided in terms of the severity of tumor-associated spinal cord injury: WHO grade I pilocytic astrocytoma, grade II astrocytoma with IDH mutation, and grade III/IV astrocytoma with H3F3A K27M mutation. This evidence concerns the gene IDH2 and neoplasm.